15 August 2016

Novartis commits 100M to boost capacity at mAb center in France

Novartis confirmed today that it is starting work on a project that will boost capacity by 70% at the Novartis Pharma S.A.S. Biotechnology Center in Huningue, France. The news actually came in an announcement by Jacobs Engineering Group which said it has been awarded a contract from Novartis to handle engineering, procurement and construction management. Jacobs said it will put in new bioreactors and build a second purification line to allow Novartis to manufacture the targeted meds simultaneously. The project is slated to be complete in four years. Novartis did not indicate whether it will be adding jobs at the site, which currently has about 400 employees. Source: Fierce Pharma 15/8/2016

My IChemE

IChemE is a registered charity in England & Wales (214379), and a charity registered in Scotland (SC 039661).